Current Oncology | Top Cited Papers in 2024–2025 in the “Gastrointestinal Oncology” Section
We are pleased to introduce a selection of the most highly cited papers published in 2024 and 2025 in the “Gastrointestinal Oncology” Section of Current Oncology (ISSN 1718-7729). For more details about this Section and to access its latest publications, please visit https://www.mdpi.com/journal/curroncol/sections/Gastrointestinal_Oncology.
1. “Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations”
by Miklos Acs, Pompiliu Piso and Gabriel Glockzin
Curr. Oncol. 2024, 31(3), 1445-1459; https://doi.org/10.3390/curroncol31030109
Available online: https://www.mdpi.com/1718-7729/31/3/109
2. “Focus on Pancreatic Cancer Microenvironment”
by Fabiana Pratticò and Ingrid Garajová
Curr. Oncol. 2024, 31(8), 4241-4260; https://doi.org/10.3390/curroncol31080316
Available online: https://www.mdpi.com/1718-7729/31/8/316
3. “Endoscopic Grading and Sampling of Gastric Precancerous Lesions: A Comprehensive Literature Review”
by Georgios Tziatzios, Dimitrios Ι. Ziogas, Paraskevas Gkolfakis, Vasilios Papadopoulos, Apostolis Papaefthymiou, Nikoletta Mathou, Athanasios Giannakopoulos, Gerasimos Gerasimatos, Konstantina D. Paraskeva and Konstantinos Triantafyllou
Curr. Oncol. 2024, 31(7), 3923-3938; https://doi.org/10.3390/curroncol31070290
Available online: https://www.mdpi.com/1718-7729/31/7/290
4. “Radiation Segmentectomy for Hepatocellular Carcinoma”
by Muhamad Serhal, Farnaz Dadrass, Edward Kim and Robert J. Lewandowski
Curr. Oncol. 2024, 31(2), 617-628; https://doi.org/10.3390/curroncol31020045
Available online: https://www.mdpi.com/1718-7729/31/2/45
5. “Radiochemotherapy in Pancreatic Cancer”
by Małgorzata Domagała-Haduch, Anita Gorzelak-Magiera, Łukasz Michalecki and Iwona Gisterek-Grocholska
Curr. Oncol. 2024, 31(6), 3291-3300; https://doi.org/10.3390/curroncol31060250
Available online: https://www.mdpi.com/1718-7729/31/6/250
6. “Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma”
by Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka et al.
Curr. Oncol. 2024, 31(8), 4225-4240; https://doi.org/10.3390/curroncol31080315
Available online: https://www.mdpi.com/1718-7729/31/8/315
7. “Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma”
by Grace Wu, Oliver J. Standring, Daniel A. King, Sepideh Gholami, Craig E. Devoe, Cornelius A. Thiels, Travis E. Grotz, Matthew J. Weiss, Richard L. Whelan, Mustafa Raoof et al.
Curr. Oncol. 2025, 32(2), 103; https://doi.org/10.3390/curroncol32020103
Available online: https://www.mdpi.com/1718-7729/32/2/103
8. “Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery”
by Hala Muaddi, LaDonna Kearse and Susanne Warner
Curr. Oncol. 2024, 31(4), 2260-2273; https://doi.org/10.3390/curroncol31040167
Available online: https://www.mdpi.com/1718-7729/31/4/167
9. “Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms”
by Graziella Masciangelo, Davide Campana, Claudio Ricci, Elisa Andrini, Emilija Rakichevikj, Pietro Fusaroli and Andrea Lisotti
Curr. Oncol. 2025, 32(2), 113; https://doi.org/10.3390/curroncol32020113
Available online: https://www.mdpi.com/1718-7729/32/2/113
by Conor D. J. O’Donnell, Umair Majeed, Michael S. Rutenberg, Kristopher P. Croome, Katherine E. Poruk, Beau Toskich and Zhaohui Jin
Curr. Oncol. 2025, 32(2), 82; https://doi.org/10.3390/curroncol32020082
Available online: https://www.mdpi.com/1718-7729/32/2/82